| Q39653970 | Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues |
| Q37182939 | Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells |
| Q74345848 | Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis |
| Q39519222 | Mechanisms of cellular resistance to cisplatin |
| Q64033465 | Mono- and bis(9-ethylguanine) complexes of trans-(CH3NH2)2PtII. X-ray structure of the 2:1 complex and redistribution of the 1:1 compound |
| Q34368410 | Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). |
| Q64033542 | Nucleobase displacement from trans-diamineplatinum(II) complexes. A rationale for the inactivity of trans-DDP as an antitumor agent? |
| Q40554527 | Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence. |
| Q40538207 | Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II). |
| Q32103947 | Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy |
| Q33180427 | Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents |
| Q38357883 | Versatile method employing basic techniques of genetic engineering to study the ability of low-molecular-weight compounds to bind covalently with DNA in cell-free systems. |